Premium
Nurix Therapeutics Inc (NRIX)
NASDAQ
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-06-02 | Dr. Christine RingChief Legal Officer, Secretary & CCO | -4,73k | 78,45k | Automatic Disposition | 16,60 | 13,58k | -25,82% |
| 2026-06-02 | Dr. Christine RingChief Legal Officer, Secretary & CCO | -3,42k | 50,44k | Derivative Exercise and Sale | 1,86 - 16,60 | 13,58k | - |
| 2026-05-05 | Mr. Johannes Van HouteCFO | -14,06k | 233,32k | Automatic Disposition | 16,58 - 17,18 | 37,59k | -27,21% |
| 2026-05-04 | Dr. Christine RingChief Legal Officer, Secretary & CCO | -8,15k | 138,21k | Automatic Disposition | 16,96 | 18,31k | -30,80% |
| 2026-05-01 | Dr. Christine RingChief Legal Officer, Secretary & CCO | -5,39k | 90,41k | Automatic Disposition | 16,76 | 26,45k | -16,94% |
| 2026-04-30 | Mr. Johannes Van HouteCFO | -2,39k | 39,75k | Derivative Exercise and Sale | 16,65 | 51,65k | - |
| 2026-04-30 | Mr. Johannes Van HouteCFO | 6,22k | 0,00 | Derivative Exercise and Retained Stock | - | 51,65k | 13,69% |
| 2026-04-30 | Dr. Christine RingChief Legal Officer, Secretary & CCO | -3,21k | 53,50k | Derivative Exercise and Sale | 16,65 | 31,85k | - |
| 2026-04-30 | Dr. Christine RingChief Legal Officer, Secretary & CCO | 5,39k | 0,00 | Derivative Exercise and Retained Stock | - | 31,85k | 20,39% |
| 2026-04-30 | Dr. Gwenn M. HansenChief Scientific Officer | -3,21k | 53,50k | Derivative Exercise and Sale | 16,65 | 120,40k | - |
| 2026-04-30 | Dr. Gwenn M. HansenChief Scientific Officer | 5,39k | 0,00 | Derivative Exercise and Retained Stock | - | 120,40k | 4,69% |
| 2026-04-02 | Dr. Christine RingChief Legal Officer, Secretary & CCO | -8,15k | 124,15k | Automatic Disposition | 15,24 | 26,45k | -23,55% |
| 2026-03-02 | Dr. Christine RingChief Legal Officer, Secretary & CCO | -8,15k | 125,79k | Automatic Disposition | 15,44 | 34,60k | -19,06% |
| 2026-02-09 | Dr. Christine RingChief Legal Officer, Secretary & CCO | -14,26k | 237,62k | Automatic Disposition | 16,66 | 42,75k | -25,01% |
| 2026-02-03 | Dr. Gwenn M. HansenChief Scientific Officer | 31,33k | 26,32k | Derivative Exercise and Retained Stock | 0,84 | 115,01k | 37,45% |
| 2026-01-30 | Mr. Johannes Van HouteCFO | 7,84k | 0,00 | Derivative Exercise and Retained Stock | - | 45,43k | 20,84% |
| 2026-01-30 | Mr. Johannes Van HouteCFO | -3,66k | 60,77k | Derivative Exercise and Sale | 16,58 - 17,37 | 45,43k | - |
| 2026-01-30 | Dr. Christine RingChief Legal Officer, Secretary & CCO | 6,11k | 0,00 | Derivative Exercise and Retained Stock | - | 57,01k | 12,01% |
| 2026-01-30 | Dr. Christine RingChief Legal Officer, Secretary & CCO | -4,42k | 73,38k | Derivative Exercise and Sale | 16,58 - 17,37 | 57,01k | - |
| 2026-01-30 | Dr. Gwenn M. HansenChief Scientific Officer | 6,92k | 0,00 | Derivative Exercise and Retained Stock | - | 83,67k | 9,02% |
| 2026-01-30 | Dr. Gwenn M. HansenChief Scientific Officer | -4,90k | 81,25k | Derivative Exercise and Sale | 16,58 - 17,37 | 83,67k | - |
| 2026-01-20 | Dr. Christine RingChief Legal Officer, Secretary & CCO | -3,76k | 62,28k | Derivative Exercise and Sale | 1,86 - 18,42 | 50,90k | - |
| 2025-12-18 | Dr. Christine RingChief Legal Officer, Secretary & CCO | -3,76k | 60,32k | Derivative Exercise and Sale | 1,86 - 18,56 | 50,90k | - |
| 2025-11-24 | Dr. Christine RingChief Legal Officer, Secretary & CCO | -37,60k | 571,76k | Derivative Exercise and Sale | 1,86 - 17,07 | 50,90k | - |
| 2025-11-03 | Mr. Johannes Van HouteCFO | -6,28k | 78,93k | Automatic Disposition | 12,56 | 37,59k | -14,32% |
| 2025-10-30 | Mr. Johannes Van HouteCFO | 8,36k | 0,00 | Derivative Exercise and Retained Stock | - | 43,88k | 23,55% |
| 2025-10-30 | Mr. Johannes Van HouteCFO | -3,13k | 40,05k | Derivative Exercise and Sale | 12,80 | 43,88k | - |
| 2025-10-30 | Dr. Christine RingChief Legal Officer, Secretary & CCO | 6,89k | 0,00 | Derivative Exercise and Retained Stock | - | 50,90k | 15,65% |
| 2025-10-30 | Dr. Christine RingChief Legal Officer, Secretary & CCO | -3,64k | 46,63k | Derivative Exercise and Sale | 12,80 | 50,90k | - |
| 2025-10-30 | Dr. Gwenn M. HansenChief Scientific Officer | 7,73k | 0,00 | Derivative Exercise and Retained Stock | - | 76,75k | 11,20% |
| 2025-10-30 | Dr. Gwenn M. HansenChief Scientific Officer | -4,09k | 52,30k | Derivative Exercise and Sale | 12,80 | 76,75k | - |
| 2025-09-17 | Ms. Julia Paige GregoryIndependent Chairman | 10,75k | 20,00k | Derivative Exercise and Retained Stock | 1,86 | 10,75k | - |
| 2025-08-01 | Mr. Johannes Van HouteCFO | -5,40k | 59,60k | Automatic Disposition | 11,03 | 35,51k | -13,20% |
| 2025-07-30 | Dr. Gwenn M. HansenChief Scientific Officer | 7,51k | 0,00 | Derivative Exercise and Retained Stock | - | 69,02k | 12,20% |
| 2025-07-30 | Dr. Gwenn M. HansenChief Scientific Officer | -4,31k | 51,74k | Derivative Exercise and Sale | 12,01 | 69,02k | - |
| 2025-07-30 | Dr. Christine RingChief Legal Officer, Secretary & CCO | 6,69k | 0,00 | Derivative Exercise and Retained Stock | - | 44,01k | 17,93% |
| 2025-07-30 | Dr. Christine RingChief Legal Officer, Secretary & CCO | -3,84k | 46,13k | Derivative Exercise and Sale | 12,01 | 44,01k | - |
| 2025-07-30 | Mr. Johannes Van HouteCFO | 7,19k | 0,00 | Derivative Exercise and Retained Stock | - | 40,91k | 21,32% |
| 2025-07-30 | Mr. Johannes Van HouteCFO | -4,30k | 51,70k | Derivative Exercise and Sale | 12,01 | 40,91k | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
